Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives $105.50 Consensus Price Target from Analysts
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) has earned an average recommendation of “Moderate Buy” from the ten analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month price target among […]
More Stories
Keanu Reeves to Host New Docuseries About Cadillac’s Journey to Join Formula 1 Race
By Audrey Enjoli A new docuseries hosted by actor and motorsports enthusiast Keanu Reeves will chronicle Cadillac’s journey to join...
House Passes GOP Megabill, Sending Measure to Trump’s Desk
By Joseph Lord, Nathan Worcester, Lawrence Wilson and Jackson Richman WASHINGTON—The House of Representatives on July 3 passed the One...
US Economy Adds 147,000 New Jobs, Unemployment Rate Dips to 4.1 Percent in June
By Andrew Moran The U.S. job market remained strong in June, as labor conditions continued to hold up amid economic...
Liverpool Soccer Star Diogo Jota Dies in Car Crash in Spain
By Guy Birchall Liverpool and Portugal soccer star Diogo Jota, 28, died in a car crash near Zamora in northwestern...
Adobe Lightroom Review: Features, Pricing & Top Alternatives
Professional photographers have been going gaga over the Adobe Lightroom Classic for years now. Recently, another version of the tool...
Tires Season 3: Release Date, Cast, Plot & Where to Watch
After the surprising hit of Season 2, Tires, brainchild of comedians Shane Gillis, John McKeever, and Steve Gerben, is set...